EDTA-induced pseudothrombocytopenia in hematopoietic stem cell donor

Misato Tsubokura; Minoru Kojima; Saori Nakabayashi; Noriko Takahashi; Sayaka Takeuchi; Yu Aruga; Chiaki Ikeda; Naoki Maezawa; Koji Okazaki; Sanshiro Uchida; Mizuki Watanabe; Jun Aoki; Ayumu Ito; Takashi Tanaka; Yoshihiro Inamoto; Sung-Won Kim; Hiromichi Matsushita; Takahiro Fukuda

doi:10.1002/ccr3.7023

EDTA-induced pseudothrombocytopenia in hematopoietic stem cell donor

Clin Case Rep. 2023 Apr 5;11(4):e7023. doi: 10.1002/ccr3.7023. eCollection 2023 Apr.

Authors

Misato Tsubokura¹, Minoru Kojima², Saori Nakabayashi¹, Noriko Takahashi¹, Sayaka Takeuchi¹, Yu Aruga¹, Chiaki Ikeda¹, Naoki Maezawa¹, Koji Okazaki², Sanshiro Uchida², Mizuki Watanabe², Jun Aoki², Ayumu Ito², Takashi Tanaka², Yoshihiro Inamoto², Sung-Won Kim², Hiromichi Matsushita¹, Takahiro Fukuda²

Affiliations

¹ Department of Laboratory Medicine National Cancer Center Hospital Tokyo Japan.
² Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan.

Abstract

We herein report a case of peripheral blood stem cell transplantation (PBSCT) involving a donor with EDTA-induced pseudothrombocytopenia (PTCP). The apheresis product was inspected for 24 h and there was no platelet clumping or thrombocytopenia. In the first 14 months after PBSCT, there has been no transfer of PTCP symptoms.

Keywords: EDTA; hematopoietic stem cell transplantation; peripheral blood stem cell harvest; pseudothrombocytopenia.

Publication types

Case Reports